- Home
- RAPT vs THTX Comparison
RAPT vs THTX Comparison
Compare RAPT & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- THTX
- Stock Information
- Founded
- RAPT 2015
- THTX 1993
- Country
- RAPT United States
- THTX Canada
- Employees
- RAPT N/A
- THTX N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- RAPT Health Care
- THTX Health Care
- Exchange
- RAPT Nasdaq
- THTX Nasdaq
- Market Cap
- RAPT 117.5M
- THTX 118.2M
- IPO Year
- RAPT 2019
- THTX N/A
- Fundamental
- Price
- RAPT $0.75
- THTX $2.62
- Analyst Decision
- RAPT Hold
- THTX Hold
- Analyst Count
- RAPT 7
- THTX 1
- Target Price
- RAPT $5.00
- THTX N/A
- AVG Volume (30 Days)
- RAPT 829.4K
- THTX 6.2M
- Earning Date
- RAPT 05-08-2025
- THTX 04-09-2025
- Dividend Yield
- RAPT N/A
- THTX N/A
- EPS Growth
- RAPT N/A
- THTX N/A
- EPS
- RAPT N/A
- THTX N/A
- Revenue
- RAPT N/A
- THTX $88,666,000.00
- Revenue This Year
- RAPT N/A
- THTX N/A
- Revenue Next Year
- RAPT N/A
- THTX $15.13
- P/E Ratio
- RAPT N/A
- THTX N/A
- Revenue Growth
- RAPT N/A
- THTX 13.52
- 52 Week Low
- RAPT $0.75
- THTX $1.08
- 52 Week High
- RAPT $8.58
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- RAPT 33.73
- THTX 57.56
- Support Level
- RAPT $0.75
- THTX $2.64
- Resistance Level
- RAPT $0.85
- THTX $2.82
- Average True Range (ATR)
- RAPT 0.08
- THTX 0.17
- MACD
- RAPT -0.00
- THTX -0.04
- Stochastic Oscillator
- RAPT 0.97
- THTX 20.45
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.